Get the Stockscreener App
0.5705
0.09%
0.0005
Purple Biotech Ltd Adr Stock (PPBT) Forecast
The Purple Biotech Ltd Adr (PPBT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.2574, representing a +120.40% increase from the current price of $0.5705. The highest analyst price target is $2.0438, and the lowest is $0.4709.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PPBT Price Target
Average 1.0284
(+80.26% Upside)
Is Purple Biotech Ltd Adr (PPBT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 11.94 | Buy |
| STOCH(9,6) | 1.8329 | Buy |
| STOCHRSI(14) | 1.5067 | Buy |
| MACD(12,26) | -0.4704 | Sell |
| ADX(14) | 39.66 | Sell |
| William %R | -97.93 | Buy |
| CCI(14) | -78.02 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.9163
Sell
|
0.9277
Sell
|
| MA20 |
1.5849
Sell
|
1.3424
Sell
|
| MA50 |
2.059
Sell
|
1.8532
Sell
|
| MA100 |
2.2503
Sell
|
2.2399
Sell
|
| MA200 |
2.7938
Sell
|
3.2894
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PPBT could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on PPBT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 11.94 indicates that PPBT is oversold. This indicates that PPBT price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 1.8329 indicates that PPBT is oversold. This indicates that PPBT price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.5067 indicates that PPBT is oversold. This suggests that PPBT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 39.66 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -78.02 indicates that PPBT is still oversold but not to an extreme extent.
Long-term PPBT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Purple Biotech Ltd Adr financial reports and earnings history, Purple Biotech Ltd Adr (PPBT) stock could reach $1.541 by 2030, $9.6263 by 2040 and $6.7396 by 2050. See the projected annual prices until 2050 of the Purple Biotech Ltd Adr stock below:
- Purple Biotech Ltd Adr (PPBT) is expected to reach an average price of $1.2302 in 2035, with a high prediction of $1.8027 and a low estimate of $1.6502. This indicates an $115.64% rise from the last recorded price of $0.5705.
- Purple Biotech Ltd Adr (PPBT) stock is projected to chart a bullish course in 2040, with an average price target of $9.7126, representing an $1,602% surge from its current level. The forecast ranges from a conservative $9.6931 to a sky-high $9.6263.
- Our analysts predict Purple Biotech Ltd Adr (PPBT) to jump 1,573% by 2045, soaring from $9.6349 to an average price of $9.5449, potentially reaching $9.7936. While $9.6349 is the low estimate, the potential upside is significant.
- Purple Biotech Ltd Adr (PPBT) stock is expected to climb by 2050, reaching an average of $6.4265, a $1,026% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.7396 and $6.4865, respectively, highlighting the market's uncertainty.
Purple Biotech Ltd Adr Stock (PPBT) Year by Year Forecast
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2025
Purple Biotech Ltd Adr Stock (PPBT) is expected to reach an average price of $1.2532 in 2025, with a high prediction of $2.4579 and a low estimate of $0.0485. This indicates an +119.67% rise from the last recorded price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $0.7597 | $0.4709 | $2.0438 | +33.16% |
| November, 2025 | $0.7371 | $0.4884 | $1.3739 | +29.21% |
| December, 2025 | $0.419 | $0.3546 | $0.8759 | -26.56% |
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2026
The predicted value for Purple Biotech Ltd Adr (PPBT) in 2026 is set at an average of $0.4599. Estimates vary from a peak of $0.9069 to a trough of $0.0129, indicating an -19.38% surge from the present price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.2765 | $0.0677 | $0.525 | -51.54% |
| February, 2026 | $0.694 | $0.3108 | $0.854 | +21.64% |
| March, 2026 | $0.4414 | $0.3471 | $0.7383 | -22.62% |
| April, 2026 | $0.3333 | $0.0129 | $0.6457 | -41.58% |
| May, 2026 | $0.3719 | $0.0977 | $0.4322 | -34.81% |
| June, 2026 | $0.3383 | $0.2183 | $0.5039 | -40.71% |
| July, 2026 | $0.0499 | $0.0786 | $0.3476 | -91.26% |
| August, 2026 | $0.1076 | $0.0224 | $0.1626 | -81.14% |
| September, 2026 | $0.7995 | $0.018 | $0.8695 | +40.13% |
| October, 2026 | $0.6269 | $0.4817 | $0.9069 | +9.89% |
| November, 2026 | $0.4744 | $0.2944 | $0.7642 | -16.84% |
| December, 2026 | $0.5263 | $0.3911 | $0.8032 | -7.75% |
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Purple Biotech Ltd Adr (PPBT) is $0.4381, with a high forecast of $0.8743 and a low forecast of $0.00184. This indicates an -23.21% decrease from the last price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4138 | $0.4138 | $0.695 | -27.47% |
| February, 2027 | $0.1962 | $0.1612 | $0.5781 | -65.60% |
| March, 2027 | $0.0369 | $0.0313 | $0.3856 | -93.53% |
| April, 2027 | $0.1006 | $0.00184 | $0.2706 | -82.37% |
| May, 2027 | $0.1381 | $0.095 | $0.2993 | -75.80% |
| June, 2027 | $0.6499 | $0.00655 | $0.7933 | +13.92% |
| July, 2027 | $0.2174 | $0.1274 | $0.8743 | -61.89% |
| August, 2027 | $0.2349 | $0.0118 | $0.3105 | -58.83% |
| September, 2027 | $0.00674 | $0.00674 | $0.3493 | -98.82% |
| October, 2027 | $0.0358 | $0.0872 | $0.0596 | -93.73% |
| November, 2027 | $0.0567 | $0.0209 | $0.1903 | -90.06% |
| December, 2027 | $0.1047 | $0.0235 | $0.3405 | -81.65% |
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2028
In 2028, Purple Biotech Ltd Adr (PPBT) is projected to reach an average price of $1.2552, with a high projection of $2.5038 and a low estimate of $0.00661. This indicates an +120.02% rise from the last price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.054 | $0.0179 | $0.2388 | -90.54% |
| February, 2028 | $2.7738 | $0.00661 | $2.5038 | +386.21% |
| March, 2028 | $1.6901 | $2.2576 | $2.4351 | +196.25% |
| April, 2028 | $2.1951 | $0.8213 | $1.3451 | +284.77% |
| May, 2028 | $1.9614 | $1.9076 | $1.9114 | +243.81% |
| June, 2028 | $1.8564 | $1.9514 | $1.7855 | +225.41% |
| July, 2028 | $0.5015 | $1.4815 | $1.979 | -12.10% |
| August, 2028 | $0.9378 | $0.8803 | $0.8565 | +64.38% |
| September, 2028 | $0.7528 | $1.0928 | $0.9928 | +31.96% |
| October, 2028 | $0.9778 | $0.6853 | $0.8278 | +71.40% |
| November, 2028 | $0.4941 | $0.5914 | $0.5291 | -13.39% |
| December, 2028 | $0.8792 | $0.7953 | $0.7492 | +54.10% |
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2029
The 2029 price forecast for Purple Biotech Ltd Adr Stock (PPBT) is $1.3404 on average, with a high prediction of $2.0931 and a low estimate of $0.5878. This represents an +134.95% increase from the previous price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7855 | $0.8355 | $0.6929 | +37.68% |
| February, 2029 | $1.3205 | $1.1286 | $1.0805 | +131.46% |
| March, 2029 | $1.0655 | $0.9842 | $0.7555 | +86.77% |
| April, 2029 | $2.2206 | $0.9268 | $1.7506 | +289.23% |
| May, 2029 | $1.7368 | $1.9256 | $2.0931 | +204.44% |
| June, 2029 | $1.2119 | $1.8181 | $1.6981 | +112.42% |
| July, 2029 | $0.4969 | $0.5878 | $0.4744 | -12.90% |
| August, 2029 | $1.4032 | $1.4809 | $1.2807 | +145.96% |
| September, 2029 | $1.3082 | $1.4172 | $1.307 | +129.31% |
| October, 2029 | $1.8945 | $1.5263 | $1.6645 | +232.08% |
| November, 2029 | $1.4296 | $1.6395 | $1.657 | +150.58% |
| December, 2029 | $1.3446 | $1.3633 | $1.2908 | +135.69% |
Purple Biotech Ltd Adr Stock (PPBT) Price Forecast for 2030
Purple Biotech Ltd Adr Stock (PPBT) is expected to reach an average price of $1.2123 in 2030, with a high forecast of $1.6585 and a low forecast of $0.7662. This signifies an +112.51% surge from the last price of $0.5705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.6509 | $1.5287 | $1.541 | +189.38% |
| February, 2030 | $1.4659 | $1.6259 | $1.5621 | +156.95% |
| March, 2030 | $1.386 | $1.4284 | $1.3572 | +142.94% |
| April, 2030 | $1.376 | $1.4222 | $1.3397 | +141.19% |
| May, 2030 | $1.6223 | $1.7372 | $1.6585 | +184.36% |
| June, 2030 | $1.4973 | $1.576 | $1.5035 | +162.46% |
| July, 2030 | $0.9436 | $0.9901 | $1.0623 | +65.40% |
| August, 2030 | $0.9086 | $0.8161 | $0.6736 | +59.27% |
| September, 2030 | $0.7637 | $0.8637 | $0.8049 | +33.86% |
| October, 2030 | $0.77 | $0.7662 | $0.6574 | +34.96% |
| November, 2030 | $0.85 | $0.7912 | $0.755 | +48.99% |
| December, 2030 | $1.12 | $0.9362 | $0.85 | +96.32% |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):